Arkolith/Insider Trading/ANIP/Form 4

Walsh Patrick D

DirectorANI PHARMACEUTICALS INC (ANIP) · full profile →Form 4 · filed May 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 13, 2026Sell(S)10K$80.63$806K38K
May 11, 2026Sell(S)4K$80.75$321K48K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001720568-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML